IMP3 and colorectal carcinoma: Altogether, our analysis identifies several pathways through which triptolide may suppress CRC proliferation, including pathways involving IMP3/ PI3K/AKT/mTOR, Hedgehog/ PI3K/AKT and ZFP36L2, AMD1, DHX9 and HNRNPC.